Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients: So Far (3 Years), So Good
- PMID: 37100484
- DOI: 10.1016/j.jacc.2023.03.006
Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients: So Far (3 Years), So Good
Keywords: aortic stenosis; aortic valve replacement; low surgical risk; prosthetic heart valve; transcatheter aortic valve implantation.
Conflict of interest statement
Funding Support and Author Disclosures Dr Pibarot holds the Canada Research Chair on Valvular Heart Diseases funded by Canadian Institutes of Health Research; and has received institutional funding from Edwards Lifesciences, Medtronic, Pi-Cardia, and Cardiac Success for echocardiography core laboratory analyses and preclinical research studies in the field of interventional and pharmacologic treatment of valvular heart diseases, for which he received no personal compensation.
Comment on
-
3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.J Am Coll Cardiol. 2023 May 2;81(17):1663-1674. doi: 10.1016/j.jacc.2023.02.017. Epub 2023 Mar 5. J Am Coll Cardiol. 2023. PMID: 36882136 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources